Cart
sales@molnova.com
Home -
Products -
Membrane Transporter/Ion Channel -
Monoamine Transporter -
Tetrabenazine Metabolite
Tetrabenazine Metabolite
CAS No. 924854-60-4
Tetrabenazine Metabolite( —— )
Catalog No. M33144 CAS No. 924854-60-4
Tetrabenazine Metabolite ((-)-β-HTBZ), a vesicles monoamine transporter 2 (VMAT2) inhibitor, is an active metabolite of Tetrabenazine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 178 | Get Quote |
|
| 5MG | 255 | Get Quote |
|
| 10MG | 374 | Get Quote |
|
| 25MG | 545 | Get Quote |
|
| 50MG | 762 | Get Quote |
|
| 100MG | 1017 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTetrabenazine Metabolite
-
NoteResearch use only, not for human use.
-
Brief DescriptionTetrabenazine Metabolite ((-)-β-HTBZ), a vesicles monoamine transporter 2 (VMAT2) inhibitor, is an active metabolite of Tetrabenazine.
-
DescriptionTetrabenazine Metabolite is an active metabolite of Tetrabenazine. Tetrabenazine Metabolite is a vesicular monoamine transporter 2 (VMAT2) inhibitor with a high affinity (Ki=13.4 nM). Tetrabenazine Metabolite is be developed for the treatment of chorea associated with Huntington’s disease and other hyperkinetic disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetMonoamine Transporter
-
RecptorMonoamine Transporter
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number924854-60-4
-
Formula Weight319.44
-
Molecular FormulaC19H29NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@]12C[C@H](O)[C@H](CC(C)C)CN1CCc1cc(OC)c(OC)cc21
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yao Z, et al. Preparation and evaluation of tetrabenazine enantiomers and all eight stereoisomers of dihydrotetrabenazine as VMAT2 inhibitors. Eur J Med Chem. 2011 May;46(5):1841-8.?
molnova catalog
related products
-
Edivoxetine
Edivoxetine (LY2216684) is a novel potent, selective norepinephrine reuptake inhibitor (NERI) being evaluated as adjunctive treatment for major depressive disorder (MDD).
-
Atomoxetine hydrochl...
A selective norepinephrine (NE) transporter inhibitor with Ki of 5 nM; shows weak affinity for 5-HT and dopamine transporters with IC50 of 77 and 1,451 nM, respectively.
-
Vanoxerine dihydroch...
Vanoxerine (GBR-12909, I-893) is a highly potent inhibitor of dopamine uptake in vitro in tissue slices obtained from rat neostriatum with IC50 of 40-50 nM.
